Opinion|Videos|June 19, 2024
Navigating Treatment Choices: Balancing Treatment Options for Childbearing-Age Patients
Dermatologists provide clinical insights on how they discuss atopic dermatitis treatment options, considerations, and safety concerns with patients who are pregnant or of childbearing age.
Advertisement
Episodes in this series
Advertisement
Related to this article
A single subcutaneous dose led to a 4-point or greater itch reduction in 82% of patients with chronic pruritus at week 12 vs 22% with placebo, Attovia reported.
Pediatric dermatologists outline how to evaluate suspected topical steroid withdrawal, exclude mimics, and preserve family trust in eczema care.
Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
ATI-052 improved disease severity and itch in a phase 1b trial of patients with severe atopic dermatitis, with no grade 3 or 4 adverse events.
The September issue highlights advances in alopecia areata, cosmetic SPF, psoriasis treatment, teledermatology, and atopic dermatitis.
Advertisement
Advertisement
Trending on Dermatology Times
1
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
2
PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies
3
Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients
4
Litifilimab Improves Cutaneous Lupus Symptoms Through 52 Weeks
5